Market Research Logo

Progressive Multifocal Leukoencephalopathy - Pipeline Review, H2 2018

Progressive Multifocal Leukoencephalopathy - Pipeline Review, H2 2018

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Progressive Multifocal Leukoencephalopathy - Pipeline Review, H2


Introduction
Global Markets Direct Report Coverage
Progressive Multifocal Leukoencephalopathy - Overview
Progressive Multifocal Leukoencephalopathy - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Products under Development by Companies
Progressive Multifocal Leukoencephalopathy - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Progressive Multifocal Leukoencephalopathy - Companies Involved in Therapeutics Development
Excision BioTherapeutics Inc
Neurimmune Holding AG
Neuway Pharma GmbH
Pomona Ricerca SRL
Progressive Multifocal Leukoencephalopathy - Drug Profiles
EBT-103 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
IkT-01427 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Monoclonal Antibody for JCV and PML Infections - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
NI-307 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
NPW-007 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
PNJC-1 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecules to Activate Sirtuin for Viral Infections - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Progressive Multifocal Leukoencephalopathy - Dormant Projects
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
Number of Products under Development for Progressive Multifocal Leukoencephalopathy, H2 2018
Number of Products under Development by Companies, H2 2018
Products under Development by Companies, H2 2018
Number of Products by Stage and Target, H2 2018
Number of Products by Stage and Mechanism of Action, H2 2018
Number of Products by Stage and Route of Administration, H2 2018
Number of Products by Stage and Molecule Type, H2 2018
Progressive Multifocal Leukoencephalopathy - Pipeline by Excision BioTherapeutics Inc, H2 2018
Progressive Multifocal Leukoencephalopathy - Pipeline by Neurimmune Holding AG, H2 2018
Progressive Multifocal Leukoencephalopathy - Pipeline by Neuway Pharma GmbH, H2 2018
Progressive Multifocal Leukoencephalopathy - Pipeline by Pomona Ricerca SRL, H2 2018
Progressive Multifocal Leukoencephalopathy - Dormant Projects, H2 2018
List of Figures
Number of Products under Development for Progressive Multifocal Leukoencephalopathy, H2 2018
Number of Products under Development by Companies, H2 2018
Number of Products by Targets, H2 2018
Number of Products by Stage and Targets, H2 2018
Number of Products by Mechanism of Actions, H2 2018
Number of Products by Stage and Mechanism of Actions, H2 2018
Number of Products by Stage and Routes of Administration, H2 2018
Number of Products by Molecule Types, H2 2018
Number of Products by Stage and Molecule Types, H2 2018

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report